Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Litwin

Showing results (31-40 of 310) with videos related to

Pageof 31
Sort By:
Pharmacoeconomics|October 17, 2002
The economic costs of early stage prostate cancerChristopher S Saigal, Mark S Litwin
World Journal of Urology|November 21, 2008
Quality of care in bladder cancer: trends in urinary diversion following radical cystectomyJohn L Gore, Mark S Litwin,
Journal of the National Cancer Institute|September 2, 2021
Does Artificial Intelligence Meaningfully Enhance Cystoscopy?Andrew T Lenis, Mark S Litwin
The Urologic Clinics of North America|May 9, 2003
The physical burden of prostate cancerDavid F Penson, Mark S Litwin
The Journal of Urology|April 20, 2010
Improving decisions for men with prostate cancer: translational outcomes researchJonathan Bergman, Lorna Kwan, Mark S Litwin
The Journal of Urology|February 22, 2011
Physician assessment of pretreatment functional status: a process-outcomes linkKarim Chamie, Natalia Sadetsky, Mark S Litwin
Cancer|September 12, 2014
Reply to Charlson score and competing mortalityTimothy J Daskivich, Mark S Litwin, Christopher Saigal
JAMA Surgery|April 5, 2013
A call to action: improving value by emphasizing patient-centered care at the end of lifeJonathan Bergman, Robert H Brook, Mark S Litwin
Nature Reviews. Urology|August 28, 2013
The future of bladder cancer care in the USAAlan L Kaplan, Mark S Litwin, Karim Chamie
Urology|May 16, 2016
Author ReplyTimothy J Daskivich, Mark S Litwin, Christopher Saigal
Pageof 31

Showing results (31-40 of 310) with videos related to

Sort By:
Pageof 31
Pharmacoeconomics|October 17, 2002
The economic costs of early stage prostate cancerChristopher S Saigal, Mark S Litwin
World Journal of Urology|November 21, 2008
Quality of care in bladder cancer: trends in urinary diversion following radical cystectomyJohn L Gore, Mark S Litwin,
Journal of the National Cancer Institute|September 2, 2021
Does Artificial Intelligence Meaningfully Enhance Cystoscopy?Andrew T Lenis, Mark S Litwin
The Urologic Clinics of North America|May 9, 2003
The physical burden of prostate cancerDavid F Penson, Mark S Litwin
The Journal of Urology|April 20, 2010
Improving decisions for men with prostate cancer: translational outcomes researchJonathan Bergman, Lorna Kwan, Mark S Litwin
The Journal of Urology|February 22, 2011
Physician assessment of pretreatment functional status: a process-outcomes linkKarim Chamie, Natalia Sadetsky, Mark S Litwin
Cancer|September 12, 2014
Reply to Charlson score and competing mortalityTimothy J Daskivich, Mark S Litwin, Christopher Saigal
JAMA Surgery|April 5, 2013
A call to action: improving value by emphasizing patient-centered care at the end of lifeJonathan Bergman, Robert H Brook, Mark S Litwin
Nature Reviews. Urology|August 28, 2013
The future of bladder cancer care in the USAAlan L Kaplan, Mark S Litwin, Karim Chamie
Urology|May 16, 2016
Author ReplyTimothy J Daskivich, Mark S Litwin, Christopher Saigal
Pageof 31